May 20, 2024 Drug-Resistant Tuberculosis–Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
May 20, 2024 Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
May 20, 2024 Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
May 20, 2024 Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
January 12, 2011 Patient Self-report for Evaluating Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
The Patient-Reported Outcome Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling Claims
February 8, 2011 Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat
The Development of a SPSS Data Dictionary and Syntax for Optimizing the Utilization of the Coalition Against Major Diseases (CAMD) AD Clinical Trial Datasets